PE20010523A1 - Procedimiento para preparar inhibidores de 5-lipoxigenasa que tienen sistemas anulares heterociclicos variados - Google Patents
Procedimiento para preparar inhibidores de 5-lipoxigenasa que tienen sistemas anulares heterociclicos variadosInfo
- Publication number
- PE20010523A1 PE20010523A1 PE2000000886A PE0008862000A PE20010523A1 PE 20010523 A1 PE20010523 A1 PE 20010523A1 PE 2000000886 A PE2000000886 A PE 2000000886A PE 0008862000 A PE0008862000 A PE 0008862000A PE 20010523 A1 PE20010523 A1 PE 20010523A1
- Authority
- PE
- Peru
- Prior art keywords
- procedure
- phenyl
- alkyl
- heterociclic
- varied
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 title abstract 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 4
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 235000010290 biphenyl Nutrition 0.000 abstract 2
- 239000004305 biphenyl Substances 0.000 abstract 2
- 239000003054 catalyst Substances 0.000 abstract 2
- 239000011541 reaction mixture Substances 0.000 abstract 2
- SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 abstract 1
- OQNBCJNBUPLGQN-UHFFFAOYSA-N 2-phenyl-2H-pyran-4-carboxamide Chemical compound C1(=CC=CC=C1)C1OC=CC(=C1)C(=O)N OQNBCJNBUPLGQN-UHFFFAOYSA-N 0.000 abstract 1
- OKIHXNKYYGUVTE-UHFFFAOYSA-N 4-Fluorothiophenol Chemical compound FC1=CC=C(S)C=C1 OKIHXNKYYGUVTE-UHFFFAOYSA-N 0.000 abstract 1
- 229940124125 5 Lipoxygenase inhibitor Drugs 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 abstract 1
- 150000001491 aromatic compounds Chemical class 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 229910052792 caesium Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical group CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 229910052701 rubidium Inorganic materials 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 229910052723 transition metal Inorganic materials 0.000 abstract 1
- 150000003624 transition metals Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE TETRAHIDRO-4-[3-(4-FLUOROFENIL)TIO]FENIL-2H-PIRAN-4-CARBOXAMIDA DE FORMULA 2.0.0; QUE COMPRENDE a)ESTABLECER UNA MEZCLA DE REACCION COMPUESTA POR 1)TETRAHIDRO-4-(3-BROMO- O YODO-FENIL)-2H-PIRAN-4-NITRILO 3.0.0; X ES Br O I; 2)4-FLUOROTIOFENOL 4.0.0; 3)EN UN DISOLVENTE TAL COMO ALCOHOL C2-C7; 4)EN PRESENCIA DE UNA BASE FUERTE M-O-R5; M ES Li, Na, K, Rb, Cs; R5 ES H, ALQUILO C1-C4; 5)EN PRESENCIA DE UN CATALIZADOR DE METAL DE TRANSICION QUE COMPRENDE UN COMPLEJO PALADIO; 6)EN PRESENCIA DE UN LIGANDO AUXILIAR PARA DICHO CATALIZADOR DE METAL DE TRANSICION QUE COMPRENDE UN COMPLEJO DE PALADIO, EL LIGANDO ES UN COMPUESTO AROMATICO 5.5.0, 5.5.1; W E Y SON P, N, O JUNTO CON R1, R2, R3, R4 SON HIDROGENOFOSFATO; m Y n SON 1-2; R1, R2, R3, R4 SON H, ALQUILO C1-C4, FENILO, NAFTILO, BIFENILO, ENTRE OTROS; ARIL1, ARIL2 SON FENILO, BIFENILO, ENTRE OTROS; p Y q SON 0-2; Z ES NR5, CH2; R5 ES H, ALQUILO C1-C4, ENTRE OTROS; b)CALENTAR LA MEZCLA DE REACCION POR 12 A 36 HORAS, OPCIONALMENTE SE AISLA EMPLEANDO TECNICAS DE SEPARACION. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE UN COMPUESTO 1.3.0, EL ANILLO CON N ES UN DIAZOL CONDENSADO OPCIONALMENTE SUSTITUIDO CON R7 Y R8; R7 Y R8 SON H, ALQUILO C1-C4, ENTRE OTROS. EL COMPUESTO ES UN INHIBIDOR DE 5-LIPOXIGENASA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15161099P | 1999-08-31 | 1999-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010523A1 true PE20010523A1 (es) | 2001-04-28 |
Family
ID=22539510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000886A PE20010523A1 (es) | 1999-08-31 | 2000-08-29 | Procedimiento para preparar inhibidores de 5-lipoxigenasa que tienen sistemas anulares heterociclicos variados |
Country Status (33)
| Country | Link |
|---|---|
| EP (1) | EP1081144A3 (es) |
| JP (1) | JP2001106686A (es) |
| KR (1) | KR20010050274A (es) |
| CN (1) | CN1286251A (es) |
| AP (1) | AP2000001909A0 (es) |
| AR (1) | AR022650A1 (es) |
| AU (1) | AU5370200A (es) |
| BG (1) | BG104730A (es) |
| BR (1) | BR0003888A (es) |
| CA (1) | CA2316748A1 (es) |
| CO (1) | CO5180623A1 (es) |
| CZ (1) | CZ20003159A3 (es) |
| EA (1) | EA200000803A3 (es) |
| EE (1) | EE200000513A (es) |
| GT (1) | GT200000144A (es) |
| HR (1) | HRP20000565A2 (es) |
| HU (1) | HUP0003437A3 (es) |
| ID (1) | ID27128A (es) |
| IL (1) | IL138089A0 (es) |
| IS (1) | IS5604A (es) |
| MA (1) | MA26750A1 (es) |
| NO (1) | NO20004312L (es) |
| NZ (1) | NZ506633A (es) |
| OA (1) | OA11451A (es) |
| PA (1) | PA8499601A1 (es) |
| PE (1) | PE20010523A1 (es) |
| PL (1) | PL342280A1 (es) |
| SG (1) | SG87145A1 (es) |
| SK (1) | SK12862000A3 (es) |
| SV (1) | SV2002000160A (es) |
| TN (1) | TNSN00176A1 (es) |
| TR (1) | TR200002530A2 (es) |
| UY (1) | UY26315A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004112837A1 (ja) * | 2003-05-23 | 2004-12-29 | Hisamitsu Pharmaceutical Co., Inc. | 非ステロイド系消炎鎮痛剤含有外用経皮製剤およびインターロイキン－１α生成抑制剤 |
| US7674811B2 (en) | 2006-03-14 | 2010-03-09 | Ranbaxy Laboratories Limited | 5-lipoxygenase inhibitors |
| CN103980312B (zh) * | 2014-05-27 | 2016-09-07 | 广州大学 | 一种n杂环双膦配体及其合成方法 |
| CN119630670A (zh) * | 2023-08-16 | 2025-03-14 | 瑞雷拉公司 | TNFα活性调节剂及其用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
-
2000
- 2000-08-01 SG SG200004340A patent/SG87145A1/en unknown
- 2000-08-10 PA PA20008499601A patent/PA8499601A1/es unknown
- 2000-08-11 CO CO00060138A patent/CO5180623A1/es not_active Application Discontinuation
- 2000-08-17 EP EP00307046A patent/EP1081144A3/en not_active Withdrawn
- 2000-08-18 OA OA1200000224A patent/OA11451A/en unknown
- 2000-08-24 TN TNTNSN00176A patent/TNSN00176A1/fr unknown
- 2000-08-24 IL IL13808900A patent/IL138089A0/xx unknown
- 2000-08-25 IS IS5604A patent/IS5604A/is unknown
- 2000-08-25 SK SK1286-2000A patent/SK12862000A3/sk unknown
- 2000-08-28 ID IDP20000710A patent/ID27128A/id unknown
- 2000-08-28 UY UY26315A patent/UY26315A1/es not_active Application Discontinuation
- 2000-08-29 GT GT200000144A patent/GT200000144A/es unknown
- 2000-08-29 CA CA002316748A patent/CA2316748A1/en not_active Abandoned
- 2000-08-29 AU AU53702/00A patent/AU5370200A/en not_active Abandoned
- 2000-08-29 BG BG104730A patent/BG104730A/xx unknown
- 2000-08-29 AR ARP000104489A patent/AR022650A1/es not_active Application Discontinuation
- 2000-08-29 PE PE2000000886A patent/PE20010523A1/es not_active Application Discontinuation
- 2000-08-30 NO NO20004312A patent/NO20004312L/no not_active Application Discontinuation
- 2000-08-30 SV SV2000000160A patent/SV2002000160A/es unknown
- 2000-08-30 BR BR0003888-1A patent/BR0003888A/pt not_active IP Right Cessation
- 2000-08-30 HR HR20000565A patent/HRP20000565A2/hr not_active Application Discontinuation
- 2000-08-30 HU HU0003437A patent/HUP0003437A3/hu unknown
- 2000-08-30 CZ CZ20003159A patent/CZ20003159A3/cs unknown
- 2000-08-30 MA MA26053A patent/MA26750A1/fr unknown
- 2000-08-30 KR KR1020000050877A patent/KR20010050274A/ko not_active Abandoned
- 2000-08-30 CN CN00126409A patent/CN1286251A/zh active Pending
- 2000-08-30 NZ NZ506633A patent/NZ506633A/en unknown
- 2000-08-31 JP JP2000262200A patent/JP2001106686A/ja active Pending
- 2000-08-31 PL PL00342280A patent/PL342280A1/xx not_active Application Discontinuation
- 2000-08-31 EE EEP200000513A patent/EE200000513A/xx unknown
- 2000-08-31 TR TR2000/02530A patent/TR200002530A2/xx unknown
- 2000-08-31 EA EA200000803A patent/EA200000803A3/ru unknown
- 2000-08-31 AP APAP/P/2000/001909A patent/AP2000001909A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR011502A1 (es) | Un compuesto substituido de acido 4-hidroxi-fenilalcanoico con actividad agonista a ppar-gamma, un metodo para prepararlo una composicion farmaceutica que lo contiene y uso del compuesto para la fabricacion de un medicamento | |
| CO5140073A1 (es) | Derivados de 2,3,4,5-tetrahidro-1h-3-benzapina | |
| ECSP045078A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplásicos | |
| DK0595851T3 (da) | Fremgangsmåde til fremstilling af sertralin-mellemprodukter | |
| ES2180508T3 (es) | Metodo para la preparacion de 5-cianoftalida. | |
| ES2161452T3 (es) | Procedimiento para la preparacion de eteres bencilicos. | |
| MA33652B1 (fr) | Agent stabilisant aminé stériquement encombré | |
| PE20020756A1 (es) | Imidazotriazinonas sustituidas como inhibidores de la fosfodiesterasa pde 2 | |
| ES2038678T3 (es) | Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos. | |
| ZA876345B (en) | Phenolic corrosion inhibitors for coating materials | |
| DK1442006T3 (da) | Fremstilling af amfetaminer fra phenylpropanolaminer | |
| PE20010523A1 (es) | Procedimiento para preparar inhibidores de 5-lipoxigenasa que tienen sistemas anulares heterociclicos variados | |
| AR048875A1 (es) | Un proceso para preparar montelukast y compuestos intermedios para el mismo | |
| AR043505A1 (es) | Preparacion de beta-cetoamidas e intermediarios de reaccion | |
| EA199900304A2 (ru) | Замещенные трициклические соединения | |
| ES8201946A1 (es) | Un procedimiento para preparar 9-aminoalquilfluorenos | |
| BR0114753A (pt) | Processo para a preparação de compostos de bis-benzazolila | |
| AR046106A1 (es) | Derivados de 2-(4-sulfonilamino) -3-hidroxi-3,4-dihidro-2h-cromen-6-ilosustituidos con amidometilo procedimiento y productos intermedios para su preparacion y medicamentos que contienen a estos compuestos | |
| YU47047B (sh) | Supstituisani 3-amino-2-benzoilcikloheks-2-enoni, postupak za njihovo dobijanje i primena za dobijanje herbicica | |
| AR015571A1 (es) | Procedimiento para la elaboracion de compuestos derivados de alfa-bromo-lactama y el uso de dichos compuestos para la preparacion de cefalosporinas | |
| PA8504601A1 (es) | Procedimiento para la preparación de compuestos de pirazolo [4,3-d] pirimidin-7-onas-3-piridilsulfonilo e intermedios de los mismo. | |
| PT96557A (pt) | Processo para a preparacao de derivados de ergolina e de composicoes farmaceuticas que os contem | |
| AR029893A1 (es) | Metodo para la preparacion de citalopram, intermediarios y composicion farmaceutica | |
| SV2002000457A (es) | Un procedimiento para preparar compuestos de bifenilo ref. x-14007 | |
| ES8707923A1 (es) | Procedimiento para la obtencion de benzamidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |